Drug Profile
NEO 312
Alternative Names: Dopamine POH; NEO-312Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator NEONC Technologies
- Class Antineoplastics
- Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants; Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in USA
- 30 Jul 2016 Early research in Cancer in USA (unspecified route)